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Abstract
There are increasing evidence of interactions between sex hormones and the structure and
function of inner ear, especially in hearing impairment and balance disorders. In this
chapter, we will discuss the mechanism of sex hormones on the inner ear, describe both
clinical and basic research that has led us to our current understanding, and conclude with
future perspectives on avenues of investigation that may lead to innovative treatments on
the hearing loss, tinnitus, and dizziness resulted from the changes in estrogen and pro-
gesterone levels. The presence of estrogen receptors α and β has earlier been shown in the
inner ear of mice. Expression of estrogen receptors (ER) correlates with the protection of
auditory function. Estrogen may have certain protective effects on the hearing. Evidence
for the treatment of sex hormone-induced symptoms is principally restricted to case
reports and retrospective studies. Recognition and understanding of sex hormone-related
inner ear problems will allow otologists to notice and manage these patients. Also, basic
studies on the mechanism of how sex hormones act on inner ear provide the way to
further prevent and treat on hearing impairment and balance disorders. High-quality
evidence for their management is limited, with further research required.
Keywords: sex hormones, inner ear, hearing, balancing functions, mechanism, treatment
methods
1. Introduction
Hearing loss, vertigo, dizziness, and tinnitus are the common symptoms in otology clinics. The
cochlea and vestibule in the inner ear are filled with endolymph and perilymph, and the
homeostasis of the water and blood circulation in the inner ear is essential for maintaining its
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hearing and equilibrium functions [1]. There are more evidence of interactions between sex
hormones and the function of the inner ear, especially in the mechanism of hearing impairment
and balance disorders in old women and pregnant women. Is the female sex steroid estrogen
the key to preserved hearing in the aging human? Is the hearing loss more profound in elderly
males than females? Is the hearing loss easier spontaneously recovered in pregnant women?
All these questions remain unanswered. In this chapter, we will discuss the mechanism of sex
hormones on the inner ear, describe both clinical and basic research that has led us to our
current understanding, and conclude with future perspectives on avenues of investigation that
will contribute to stratification strategies on the hearing loss, tinnitus, autophony, and dizzi-
ness resulted from the changes in sex hormone levels.
2. How the different sex hormones may influence the inner ear
The sex hormones, including estrogen, progesterone, and androgen, are known to be impli-
cated in normal auditory function in different proportions [2]. It is the balance of all three
hormones in the body that promotes human health and vitality, including inner ear functions.
Estrogen is usually thought of a “female” hormone; it may act as an auditory protectant; it is
made in the ovaries, adrenal glands, and fat cells; and its levels are higher in those of repro-
ductive age, which is helpful to prevent bone loss and works toward maintaining good
cholesterol levels. Estrogens are known to facilitate the loss of intravascular fluid into the
extravascular space, producing edema; however, blood vessel permeability, blood circulation,
or inflammation has been reported to be related to the inner ear diseases. Progesterone is the
sex steroid frequently mentioned for sexual health. In women, it is produced in the ovaries and
through ovulation, which performs different benefits in balancing the unwanted effects of
estrogen, helping the body use fat for energy, maintaining healthy weight, promoting restful
sleep, and protecting against breast and uterine cancer; however, it may have a negative effect
on hearing [3]. Androgen is a “male” hormone, the primary and most well-known androgen is
testosterone, produced in the testicles and to a lesser degree in the adrenal glands, which helps
build muscle tome, increases energy, contributes to a healthy libido, and aids in sperm pro-
duction [4]. Healthy levels are also important in women; testosterone is produced in the female
ovaries and a small amount is made in the adrenal glands, which helps to increase libido,
promote musculoskeletal tone and strength, and raise energy levels. When testosterone is too
high, however, it can lead to acne, unwanted hair on the face and body, polycystic ovaries with
resulting interference of ovulation, and aggression among other concerns. Getting all three sex
hormones balanced can be helpful for both men and women, and the results often offer clues
on how to prevent unwanted inner ear symptoms in the future.
2.1. Estrogen
Estrogens influence physiological functions of many organs and systems in both female andmale,
including the skeletal, cardiovascular, and nervous systems, as well as the male urogenital tracts,
mammary glands, and female reproductive organs. Estrogen could lead to neural excitation and
thus facilitate auditory transmission, but the possible increase in neurosteroids in the brainstem
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may counteract this effect. Estrogen may act as an auditory protectant, which influences the inner
ear at different levels, at the cochlea, vestibular organs, and more proximal levels.
Estrogens are mediated through estrogen receptors (ERs). There are at least three and possibly
four distinct estrogen receptors. The most common estrogen receptors are ERα, which is
encoded by a gene on chromosome 6, and ERβ, encoded by a gene on chromosome 14. Other
ERs include G protein-coupled receptor (GFER, GPR30, and a putative receptor (ER-X), which
has been studied mostly in brain [5]. Estrogen receptors α and β containing cells were also
found in the inner ear, with a specific distribution pattern, both in auditory pathways and in
the water/ion regulating areas. The presence of ERs in the inner ear cell nuclei implies that
estrogen may have an influence on the inner ear and auditory functions. Estrogen receptors
have been found in the inner ear of rats and mice in different cell types, including inner and
outer hair cells, stria vascularis, spiral ligament, Reissner’s membrane, and spiral ganglion
cells especially type I cells [5]. Moreover, estrogen receptors in the auditory epithelium of
vertebrates also occur in fishes [6], cichlid [7], songbird [5], and rodents [8], which suggest a
widespread occurrence of steroid-dependent auditory plasticity among the vertebrates.
But in adult human inner ear, ERα-containing cells were only found in the spiral ganglion, and
ERβ-containing cells in the stria vascularis selectively, which are important for hearing trans-
mission and inner ear homeostasis [8]. It has been shown that there is less expression of ERα in
strial marginal cells, outer hair cells, and type II ganglion cells [9]. ERα and ERβ are regulated
depending on the stage of maturation, development, and pregnancy, suggesting that estrogen
may have an effect on the cochlea during different life time. ERs were not found in the cochlea
of the growing fetus, which implied that estrogen does not have an influence on the cochlea
during the period of gestation [10]. Estrogen receptor mRNA is expressed in supporting cells
with similar functions within the saccular epithelium of midshipman fish [6].
The expression of ERα was found in forebrain nuclei, including anterior parvocellular (PPa)
and anterior tuberal (AT), which are sites of the integration between auditory and vocal motor
system [11], and anterior tuberal is densely innervated by the neuropeptides, arginine vasoto-
cin and isotocin, which modulate vocal motor patterning in midshipman [12–14]. Also, in
some gene knockout studies, estradiol plays an important role in the regulation of both
vasopressin and oxytocin, especially by ERα in limbic regions [15, 16] and by ERβ in hypotha-
lamic areas [17].
The expression of ERs in known target organs is influenced by the amount of estrogen in the
serum. Lots of studies have shown a gender difference in hearing function. And some of them
suggested that part of this variation was because of the difference in estrogen levels between
the two genders. As for the expression pattern of ERs, there is no gender- or age-related
difference to be found. However, the fluorescence intensity of ERα was stronger in female
mice than in young male ones. To compare with, ERβ showed no significant difference. Also,
the expression of ERs decreased with age. In the old mice, the fluorescence intensities of ERs
were significantly decreased in both male and female [9].
Many clinical and basic studies have proved that estradiol plays an important role in auditory
physiology, neuronal plasticity, and the metabolic levels of neurotransmitters [18, 19]. ERαmight
change cochlea and vestibular sensory transduction, and ERβmay have a neuroprotective effect
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in the inner ear [9]. ERβ protects the auditory system from acoustic trauma in young male and
female mice. ERβ in accordance with brain-derived neurotrophic factor (BDNF) promotes neu-
ronal plasticity and protection against trauma in the auditory system [20]. But experimental
estrogen-induced hyperprolactinemia leads to hearing loss in the guinea pig. It suggests that otic
capsule and hair cell pathology related with estrogen-induced prolonged hyperprolactinemia
and conditions such as pregnancy may lead to similar auditory pathology [21]. 17β-estradiol
leads to adjustments in the molecular biology of the cochlea and the inferior colliculus of mouse
accompanied with behavioral alternations [22]. Estrogen-related receptor gama (ESSR) plays a
role in maintenance of hearing in both humans and mice [23].
2.2. Progesterone
Progesterone is secreted principally by the granulosa lutein cells of the corpus luteum, which
are formed from granulosa cells after the luteinizing hormone surge. Progesterone is the main
hormone of pregnancy, and in pregnancy, after week 8, the placenta replaces the corpus
luteum as the main source of progesterone. Several steroids have similar properties and are
together classified as the “progestogens.” These include 17α-hydroxyprogesterone and preg-
nenolone as well as progesterone itself.
The two main progesterone receptors are progesterone receptor-A and progesterone receptor-B.
And, there are two isoforms of the progesterone receptor encoded by the same gene, but with
different start sites for transcription, hence the increased size of progesterone receptor-B com-
pared with progesterone receptor-A. Expression of the progesterone receptor is regulated by
estrogens, while progesterone receptors have an important effect, mediated by progesterone
receptor-A, in inhibiting the proliferative actions of estrogen. For this reason, progesterone is
nearly always given in addition to estrogen therapy, for example, in the oral contraceptive pill
and in hormone replacement therapy. The presence of progesterone as a component in hormone
replacement therapy leads to poorer hearing in aged women, affecting both the peripheral and
central auditory system, and it interferes with the perception of speech in background noise [21].
Nevertheless, there is no direct nuclear effect of progesterone in the inner ear. There is no
nuclear progesterone receptor being found in human or rat stria vascularis, organ of Corti or
spiral ganglion with immunohistochemistry, or polymerase chain reaction (PCR). But, proges-
terone receptor-B is being found with Western blot in the cochlea. It probably indicates the
staining in the cochlea bone. In this case, the effect of progesterone on hearing is probably not
relevant to the action in the inner ear [25].
Progesterone receptors are important for integration of external signals and internal physio-
logical cues in the brain to output an appropriate behavior. In a study using the frog,
Physalaemus pustulosus, as a model system, progesterone receptor immunoreactivity was found
in key brain regions known to modulate the processing of auditory clues [26].
2.3. Androgen
Androgens, which are produced by Leydig cells, like all steroid hormones, are made from
cholesterol. A range of androgens is made in the body and, although most of these come from
the testes, some are made in the adrenal cortex. The most potent and important of these
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androgens is testosterone, and by far the highest production of testosterone is in the testes.
Testosterone has two main actions: the initiation of spermatogenesis and the development and
maintenance of secondary sexual characteristics. In order to achieve the second group of
actions, testosterone must be converted to 5α-dihydrotestosterone (DHT). This conversion
happens outside the testes, in peripheral tissues. Furthermore, both testosterone and DHT act
on the same receptor, the androgen receptor (AR).
In contrast to these well-known effects of estradiol on hearing function, relatively little is
known about how androgens might influence hearing or whether androgen receptors (AR)
are also expressed in the inner ear of vertebrates. The lack of regenerative ability of adult
mammalian cochlea and the irreversible degeneration of cochlear sensory hair cells leads to
permanent hearing loss. Whether the androgen receptors (ARs) establish in the inner ear, there
are many studies on it, in a transcriptomic analysis of the developing and adult mouse
cochlear sensory epithelia, the adult cochlear sensory epithelium overexpressed 2542 tran-
scripts including new transcripts, such as AR, which previously were not reported to be
expressed in the adult cochlea [27].
In all major vertebrate animals, androgen receptors have been identified in neural circuits that
shape vocalization. Many of those nuclei mentioned above are part of the known vocal and
auditory circuit in midshipman. The distribution of androgen receptor mRNA supports that
androgens modulate behaviorally defined vocal, auditory, and neuroendocrine circuits in
teleost fish and vertebrates in general [28].
Additionally, testosterone in serum increased neural thresholds in females in a frequency-specific
way [29]. And hyperandrogenism may be responsible for the elevation of hearing threshold,
particularly in the high frequency, in patients with polycystic ovary syndrome [30–32]. On the
contrary, hyperandrogenism did not seem to affect otoacoustic emission levels or the medial
olivocochlear reflex response in adult female subjects [33].
In audiology, the usage of biomedical interventions and biotherapeutic methods could play an
important role in modulating or preventing some kinds of hearing loss. Planar cell polarity is of
high importance as it regulates cochlea extension and coordinates orientation of sensory hair
cells in the inner ear. If we could use the effect of sex hormone in the inner ear, the establishment
of ectopic hair cell-like cell polarity could be built. Testosterone is related to the neuroprotection
and regeneration in central nervous system. We could promote an increase in hair cell-like cell
polarity in the LER through proliferation and transdifferentiation by using testosterone-3-(O-
carboxymethyl) oxime bovine serum albumin and Math1 treatment [34]. In the treatment of
immune-mediated sensorineural hearing loss, it was confirmed that testosterone has the preven-
tive and therapeutic effects induced by sensitization using bovine inner ear antigens [35].
3. Physiological variation in sex hormones and effect on inner ear
The levels of sex hormones vary in response to endogenous and exogenous stimuli and many
vary in a cyclic fashion. The endocrine changes related to reproductive function (ovarian cycle,
pregnancy, and menopause) could in turn affect auditory and balance function. Additionally,
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there are multiple interactions between the sex hormones involved in these physiological
changes and this enhances the possible multidirectional effects on the inner ear.
3.1. Ovarian cycle
In the ovarian cycle, the levels of estrogen and progesterone in the body have a dynamic
regulation. Both clinical and basic studies have proved that the changes of auditory and
balance system are attributed to estradiol and progesterone. In other words, the fluctuating
hearing levels are evident in females during the ovarian cycle. Across the life span, both
women and men undergo transitions in reproductive status related in part to changes in sex
hormone levels. There is controversy over how hormonal conditions influence cerebral physi-
ology related to evoked potentials and perceptual speech processing in women during ovarian
cycle. Hearing thresholds change upon different sex hormone levels during the menstrual
cycle [36]. And hearing conduction, measured by auditory brainstem response, is better in
postovulatory phase compared with preovulatory phase of menstrual/ovarian cycle [37]. Also,
brainstem auditory evoked potentials change in the mid follicular and the mid luteal phases of
the ovarian cycle [38]. Moreover, ovarian cycle effects on postural stability but not optokinetic
function, and this needs to be considered when conducting studies of postural stability in
women [39]. Studies of dichotic listening in women of the reproductive age also show that
there is variation in laterality as a function of menstrual cycle phase. The perceptual speech
processing of women is highly plastic and operates at varying states of functional asymmetry
across days of the menstrual cycle, which are consistent with other works showing menstrual
cycle-related changes in lateralized neurocognitive systems in the language domain [40–42].
3.2. Menopause
More organs are found to be influenced by the positive effects of estrogen, and estrogen has
been expected to be benefit on auditory system by many investigators. As for the postmeno-
pausal women, many studies suggested that the hearing and balancing problem appeared
might be related to their sex hormone levels. Hearing loss in older people usually affects the
highest frequencies early on and gradually affects the lower frequencies. Progesterone may
have negative effects on the hearing of pre- and postmenopausal women and aging mice. On
the contract, estrogen was found in some situation to have a positive influence [25]. The
auditory brainstem response thresholds of postmenopausal female are higher than younger
men or women [43, 44]. And the lower level of circulating serum estradiol possibly impedes
hearing sensitivity in postmenopausal women, which has no relationship with bone mineral
densities [45].
Intrinsic estrogen at physiological levels might slow down hearing loss in aging women [46].
At the same time, estrogen therapy may slow down the hearing loss in aging postmenopausal
women [47]. Tibolone, a synthetic steroid drug with estrogenic, progestogenic, and weak
androgenic actions, is often used in the hormone replacement therapy for menopausal or
premenopausal women. And tibolone had no negative effect on hearing function and might
decelerate hearing loss in aging postmenopausal women, intrinsic estrogen at physiological
levels might slow down hearing loss in aging women [46]. After treatment of healthy
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menopausal women with tibolone for 6 months, the improvement was more prominent on the
right side in audiometry results at low frequency. It may be explained by differences in
distribution of ER in the ear. ERs might be more dense in the right ear, so give better response
to estrogen therapy [47]. Many studies have showed that estrogen affects hearing function,
especially in the postmenopausal women; a recent study gets a result that there may be
hearing lateralization in menopausal women, especially significant improvement on right ear
can be explained by lower BMD on that side ear bones in turn better response to estrogen
therapy due to this, which may be related to ER concentration and the more dense of type ERα
and/or ERβ in the right ear [48].
According to the vestibular function, the level of estradiol and progesterone decreases obvi-
ously in postmenopausal women with benign paroxysmal positional vertigo, which can cause
the inner ear microcirculation disorder, may be a risk factor of BPPV [49].
Although estrogen has been expected to be benefits on auditory system, both clinician and
patients need to take into concern that estrogen may have some unwanted side effects, such as
increased risk of uterine cancer. Because in the central nervous system, ERβ is highly expressed
in neurons and glial cells. And there is little ERβ in the mature uterus, selective ERβ agonists,
then they become available [50, 51].
3.3. Pregnancy
Hearing loss appeared in pregnancy is not a commonly reported problem. Some investiga-
tors have noticed reversible and physiological sensorineural hearing loss at low frequencies
during the period of pregnancy [52, 53]. In some case reports, sudden onset of sensorineural
hearing loss during pregnancy has been described [54], and one report concerning a patient
who had the hearing loss with each serial pregnancy [55]. But a nationwide population-
based study suggested that sudden sensorineural hearing loss (SSNHL) in pregnancy is rare.
SSNHL is defined as sudden, idiopathic, usually unilateral deafness developed at most in
72 hours in previously healthy people [56]. It often happens in the third trimester. And
SSNHL in pregnancy does not increase the risks of delivery or subsequent stroke [57]. As
for the mechanism, there is a hypothesis implied that SSNHL is connected with the changes
in cardiovascular system, hematological system, and/or some other systems because of
pregnancy. These changes in pregnancy may evoke disorders of cochlea circulation or
cochlea fluid homeostasis resulting in SSNHL [57]. Otosclerosis is one of the most common
causes of acquired hearing loss and is widely supposed as being related with pregnancy.
Another study revealed that resonance frequency of middle ear was found to be low during
the third trimester of the pregnancy. And low resonance frequency informs that the acoustic
immittance of the middle ear changes during pregnancy [58].
Tinnitus is another auditory symptom in pregnant patients, with proposed theories of patho-
genesis, including hyperdynamic circulation, increase in perilymphatic fluid pressure, and
hormonal changes. Clinically, it appears that the hearing loss and tinnitus related to pregnancy
can spontaneously recover. As for treatment, it depends on the otorhinolaryngologic doctors to
decide whether they should administer steroid drugs for acute hearing loss, as it may recover
after the delivery [54].
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Autophony is a classic complaint of patients suffering from a patulous Eustachian tube (PET).
The typical patients with PET have lost a drastic amount of weight, resulting in shrinkage of
the peritubal mucous membranes. One third of the patients with PET are either pregnant or
taking an estrogen replacement therapy [59]. In order to resolve the symptoms postpartum,
management should consist of informative reassurance alone [60].
There is an increase in incidence of Bell’s palsy (BP) during pregnancy [61]. One of the reasons
could be a brain stem synaptic impairment caused by estrogen, presumably because of ische-
mic changes [62]. And most of them seem to be concentrated in the third trimester. The most
likely explanation about the concentration in the third trimester may be the altered suscepti-
bility to herpes simplex viral reactivation during pregnancy. And the prognosis of pregnant
patients may be poorer [63].
3.4. Gender differences in auditory function
Many authors have shown that a gender differences in auditory function and some of them
implied that part of this variation was due to the difference in estrogen levels between females
and males. There are well-known sex differences in the auditory brainstem response, with
women having shorter latencies than men [64]. Hearing loss is more profound in elderly males
than females. Many early studies on otoacoustic emissions revealed the existence of sex and ear
differences in human beings. Some also revealed that the sex and ear differences in adults are
evident in newborns as well. These differences are in the direction of human females having
stronger and more numerous spontaneous otoacoustic emissions and stronger click-evoked
otoacoustic emissions than do males; also, human right ears have stronger and more numerous
spontaneous otoacoustic emissions and stronger click-evoked otoacoustic emissions than do left
ears. There is a so-called prenatal-androgen-exposure explanation. Prenatal androgen exposure
apparently can alter auditory evoked potentials. The sex difference in otoacoustic emissions in
newborns may be that the prenatal androgen exposure in some way weakens the cochlea
amplifiers and thereby weakens spontaneous otoacoustic emissions and click-evoked
otoacoustic emissions (and perhaps distortion product otoacoustic emissions less markedly) [65].
Sex differences are limited to frequency ranges, which are related to the processing of natural
vocalizations and depend on the type of stimulus. In a research using green tree frog, Hyla
cinera, sex did not change audiogram best frequencies, although sex did make a difference in
the sensitivities at those frequencies with males more sensitive in the lower frequency range
[29]. The auditory system exhibits differences by sex and by sexual orientation, and the
implication is that relevant auditory structures are altered during prenatal development,
possibly by exposure to androgens [66].
Gender differences also occur in some pathological situations. In the presence of sex hormone
receptors in human middle ear cholesteatoma, stronger expression of progesterone receptor
was found in samples from male patients, while stronger expression of estrogen receptor was
found in samples from female patients. It suggests that female sex hormones may stimulate
proliferation of middle ear cholesteatoma keratinocytes [67]. Estrogen levels between females
and males in different ages may influence the function of the auditory systems, and the details
of the mechanism should be studied in the future.
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4. Sex hormones and auditory and vestibular pathology
Considerable anecdotal evidence and limited information from previous studies suggest that
auditory and vestibular functions may be influenced by sex hormones resulting in pathological
conditions such as hearing disorders in Turner syndrome, Presbyacusis, Otosclerosis, and
Menière’s disease.
4.1. Hearing disorders in Turner syndrome
Hearing disorders are obvious in mice and women with Turner syndrome (total or partial loss
of one X chromosome) [68]. Approximately one-half of women with TS have a 45,X karyotype,
about 20% have 45,X/46,XX mosaicism, and the remainder have structural abnormalities of the
X chromosome such as X fragments, isochromosomes, or rings. TS is characterized by bilateral
streak gonads, short stature, primary amenorrhea, streak ovaries, and no estrogen production,
which often develop an early presbyacusis.
The hearing loss features in patients with Turner Syndrome should be taken into consideration.
The common clinical complaints are recurrent otitis media, dysfunction of the Eustachian tube,
conductive hearing loss during infancy, and sensorineural hearing loss in the adolescence. The
karyotype appears to be important in the hearing loss, with studies demonstrating an increased
prevalence in patients with monosomy 45,X or isochromosome 46,i (Xq). It is necessary of
morphologic studies of the cochlea to help out in clarifying the etiology of the sensorineural
hearing loss [69]. And sensorineural hearing loss is the most common type of hearing loss. It is
mostly characterized by a high-frequency loss and/or a mid-frequent dip. It is uncommon for
conductive hearing loss in young women with Turner Syndrome. But in a TS cohort, 91% of
patients suffered middle ear disease, but the incidence of SNHL was 9%. It is suggested that TS
patients should be screened for onset and progression of hearing loss [70]. Consequently, there is
a need for hearing rehabilitation in these patients. Questions about hearing must be asked by
physicians when treating women with Turner Syndrome to identify those who need hearing
rehabilitation, even if they have an audiogram with a normal pure tone average [71].
Both the karyotype and sensorineural dip in hearing could be used to predict the future course of
hearing levels for TS patients. And estrogenmay have an influence on hearing loss in TS patients [72].
Progressive hearing loss is relatively common in human without a clear molecular basis and
medical therapies. A new gene, WBP2, was defined to be involved in the molecular pathway
linking hearing impairment to hormonal signaling and provides new therapeutic targets. WBP2
is required for normal glutamatergic synapses in the cochlea and is crucial for hearing [73].WBP2
encodes the protein that acts as a transcriptional coactivator for ERα (ESR1) and progesterone
receptor. The loss ofWbp2 expression leads to progressive high-frequency hearing loss in mouse,
as well as in two deaf children, each carrying two different variants in the WBP2 gene [73].
4.2. Presbyacusis
Presbyacusis or age-related hearing loss is a complex degenerative disease that affects many people
worldwide. Gender does play a role in age-related hearing loss. Longitudinal studies of aging have
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shown that hearing declines more rapidly in males than females. Elderly people with presbyacusis
not only have a loss in sensitivity to sound but also have significant difficulties understanding
speech in background noise at supra-threshold, conversational levels. Many researchers have
identified sex-specific differences in presbyacusis in humans and animal models [74].
There is growing evidence that interactions between sex hormones and sensory systems are
sometimes beneficial, but oftentimes detrimental, such as progesterone with negatively affect
hearing in older women, whereas in some cases, estrogen may have positive effects [24]. Data
from a large cohort of adults (48–92 years) in the Beaver Dam Epidemiology of Hearing Loss
Study show significant age effects in word recognition scores in competing messages for both
men and women, but performance is consistently poorer in men than in women at all age
groups and hearing loss categories [75].
4.3. Otosclerosis
Otosclerosis is a major cause of acquired hearing loss in adult life affecting exclusively the
human temporal bone, which is reported to worsen during periods of intense hormonal
activity. Many researchers show a possible link between aggravation of otosclerosis and preg-
nancy is still debated. Thus, sex hormones were believed to be involved in the progression of
the disease. Estrogen deficiency is considered to be a cause of osteoporosis in menopause
women, and estrogen substitute therapy has shown beneficial effect in those cases [76].
Otosclerosis becomes manifest between the ages of 20–50 years and is usually bilateral. It
affects twice as many females as males [77]. A retrospective study on a sample of 479 women
with otosclerosis showed that the risk of subjective hearing deterioration with bilateral oto-
sclerosis increased from 33% after one pregnancy to 63% after six pregnancies [78]. Several
reports have suggested that oral contraceptives may increase the risk of hearing loss and in
particular otosclerosis, although no clear conclusion has been drawn [79].
Estrogen has an inhibitory effect on bone resorption by directly inhibiting osteoclast activity as
well as decreasing auto and paracrine production of cytokines such as interleukin (IL) 1 and IL-6
and tumor necrosis factor, TNF [80]. Researchers investigated the effect of 17β-estradiol on bone
remodeling via diastrophic dysplasia sulfate transporter (DTDST) in otosclerosis and in a human
osteoblast-like cell line, and they have demonstrated that the response to estrogens in terms of
DTDST activity might be related to the expressed receptor type. It is possible that exacerbating
effects of estrogens in patients with otosclerosis may be mediated by peculiar profiles of estrogen
receptor in otosclerotic cells [81]. However, the regulatory mechanisms of Otosclerosis related to
the estrogen receptor profile in the otosclerotic cells need to be further analyzed.
4.4. Menière’s disease
Menière’s disease is characterized by hearing loss, tinnitus, and vestibular dysfunction. It is
thought that endolymph malabsorption is the underlying cause of the swelling of the endo-
lymphatic spaces. Estrogens are known to facilitate the loss of intravascular fluid into the
extravascular space, producing edema. Endogenous alterations in concentrations of estrogen
and progesterone in the premenstrual syndrome or with the use of exogenous hormones such
as oral contraceptives may trigger vertigo in patients with Menière’s disease. Many reports
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show that women with Menière’s disease were identified as having premenstrual phase of
their monthly cycle or during pregnancy [82]. Genetic factors could contribute, at least par-
tially to it. Many researchers have identified that in some women with Meniere’s disease,
attacks of vertigo, low frequency hearing loss, aural fullness and tinnitus are exacerbated in
the premenstrual phase, when estrogen levels are low with edema in the endolymphatic
spaces due to the loss of intravascular fluid into the extravascular space facilitated by estrogens
[83–85]. One possible explanation may be estrogen-induced hyperprolactinemia, which was
reported to provoke hearing loss and otic capsule dysmorphology in guinea pig [24].
Significant associations have been reported between Menière’s disease and genetic polymor-
phisms. Polymorphisms associated with blood vessel permeability, blood circulation, or
inflammation have been reported to be related to the inner ear pathology. AQP5 is known as
an exocrine-type water channel with the roles in conveying a high degree of membrane water
permeability [86]. Mice lacking AQP5 show lower frequency hearing impairment [87]. Some
researchers demonstrated identified AQP5 as an ESα target gene in the mouse uterus using
chromatin immunoprecipitation and DNA microarray analyses [88].
5. Summary
Sex hormone-related symptoms of auditory and vestibular systems are common in clinic.
Here, we address by recognizing that interactions between sex hormones and sensory systems
can be beneficial or detrimental to the peripheral and central auditory and vestibular systems.
Knowing how sex steroids can alter hearing ability may give important clues as to how
estrogen can preserve hearing in humans. The postmenopausal women have slightly better
hearing if administered estrogen replacement therapy, physiological levels of estrogen would
seem to have a possible protective effect on hearing function. The association described here
shed light to the role of sex hormones and their receptors in the inner ear and behavior and
underline the therapeutic potential of specific sex hormone agonists and antagonists.
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